Dr. Elizabeth A. Dinces, MD

Dr. Dinces practices at Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein.

Dr. Dinces' NPI, 1295806677, was assigned on November 10, 2006. Dr. Dinces graduated from Albert Einstein College of Medicine in 1991. Dr. Dinces holds New York license 210523.

Dr. Dinces' primary practice is Montefiore Einstein Hospital-Moses Campus, at 111 East 210th Street, Bronx, NY 10467 in Bronx County. The practice phone is (718) 920-4321.

Dr. Dinces' primary practice is Montefiore Einstein Hospital-Moses Campus in Bronx, New York, part of Montefiore Einstein. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Dinces to 1 more group practice or clinic and 1 school health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dinces practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Dinces' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Dinces is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Dinces' licenses on file in 3 states: New York, Illinois and New Jersey.

Dmand AI lists chronic ear infection, ear eustachian tube disorders, ear infection, hearing loss and impairment, swimmer's ear, tinnitus and vertigo among the conditions Dr. Dinces treats.

CMS data shows 153 Medicare services from Dr. Dinces across 5 procedure codes in 2024, for 109 Medicare patients. Medicare paid $10,023 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 109 Medicare patients who saw Dr. Dinces in 2024. The largest group is 75 to 84, with 42 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 44% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dinces' median patient age at 61, with 66% women.

In 2024, Dr. Dinces wrote 163 Medicare Part D claims for 67 patients. 91% of them were for generic drugs. CMS names the drug for 83 of them, across 4 drugs with 11 or more claims each, at $2,570 in total drug cost. In 2023, CMS named 75 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dinces for performance year 2024, reported as part of a group. CMS lists Dr. Dinces as offering telehealth.

Dmand AI links 13 papers to Dr. Dinces, published from 2008 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Evoked Potentials, Auditory, Auditory Perception and Electroencephalography. Dr. Dinces has published most often in Int J Pediatr Otorhinolaryngol. Dr. Dinces' most frequent co-authors are Amit Chopra, MD, Jacob Boston Hunter, MD and David P. Lee, MD, MPH.

Dmand AI links Dr. Dinces to 1 clinical trial. Conditions studied include Tinnitus and Hearing Disorders.

CMS Open Payments shows 7 general payments to Dr. Dinces from 2 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 89% of the total. Merck Sharp & Dohme Corporation paid the most, $3,500.

Dmand AI lists 2 awards for Dr. Dinces, most recently Fellow in 2012.

Dr. Dinces graduated from Albert Einstein College of Medicine in 1991. Dr. Dinces is a member of NHS.